Preliminary experience in treating thoracic spinal tuberculosis via a posterior modified transfacet debridement, instrumentation, and interbody fusion

Abstract Background Posterior transfacet approach has been proved to be a safe and effective access to treat thoracic disc herniation. However, the therapeutic effect and safety of modified transfacet approach for treating thoracic spinal tuberculosis (TST) has not been reported in the clinical lite...

Full description

Bibliographic Details
Main Authors: Yun-Peng Huang, Jian-Hua Lin, Xiao-Ping Chen, Gui Wu, Xuan-Wei Chen
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13018-018-0994-8
id doaj-c400c5ab702c4d8b9eb8d8aab3708e9e
record_format Article
spelling doaj-c400c5ab702c4d8b9eb8d8aab3708e9e2020-11-25T02:03:39ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2018-11-011311910.1186/s13018-018-0994-8Preliminary experience in treating thoracic spinal tuberculosis via a posterior modified transfacet debridement, instrumentation, and interbody fusionYun-Peng Huang0Jian-Hua Lin1Xiao-Ping Chen2Gui Wu3Xuan-Wei Chen4Department of Spine Surgery, The First Affiliated Hospital of Fujian Medical UniversityDepartment of Spine Surgery, The First Affiliated Hospital of Fujian Medical UniversitySchool of Mathematics and Informatics, Fujian Normal UniversityDepartment of Spine Surgery, The First Affiliated Hospital of Fujian Medical UniversityDepartment of Spine Surgery, The First Affiliated Hospital of Fujian Medical UniversityAbstract Background Posterior transfacet approach has been proved to be a safe and effective access to treat thoracic disc herniation. However, the therapeutic effect and safety of modified transfacet approach for treating thoracic spinal tuberculosis (TST) has not been reported in the clinical literature. In this study, the clinical efficacy and safety of a single-stage posterior modified transfacet debridement, posterior instrumentation, and interbody fusion for treating TST were retrospectively evaluated. Patients and methods From 2009 to 2014, 37 patients with TST underwent a posterior modified transfacet debridement, interbody fusion following posterior instrumentation, under the cover of 18 months of antituberculosis chemotherapy. The patients were evaluated preoperatively and postoperatively in terms of Frankel Grade, visual analog scale (VAS) pain score, kyphotic Cobb angle, and bony fusion. Results The follow-up time was 39.8 ± 5.1 months (29–50 months). No postoperative complication or recurrence of spinal tuberculosis was observed. Definitive bony fusion was achieved in all patients. At the final follow-up, 2 cases were rated as Frankel grade D, 35 as grade E. VAS was recovered from 8.4 ± 1.0 cm to 0.4 ± 0.8 cm. The kyphotic angles were corrected from 29.4 ± 10.9° to 17.6 ± 6.3°. Using the Kirkaldy-Willis criteria, functional outcome was excellent in 29 patients, good in 7, and fair in 1. Conclusions Our preliminary results showed that single-stage posterior modified transfacet debridement, posterior instrumentation, and interbody fusion are effective and safe surgical options for treating TST.http://link.springer.com/article/10.1186/s13018-018-0994-8Focal debridementModified transfacet approachSurgical treatmentThoracic spine tuberculosis
collection DOAJ
language English
format Article
sources DOAJ
author Yun-Peng Huang
Jian-Hua Lin
Xiao-Ping Chen
Gui Wu
Xuan-Wei Chen
spellingShingle Yun-Peng Huang
Jian-Hua Lin
Xiao-Ping Chen
Gui Wu
Xuan-Wei Chen
Preliminary experience in treating thoracic spinal tuberculosis via a posterior modified transfacet debridement, instrumentation, and interbody fusion
Journal of Orthopaedic Surgery and Research
Focal debridement
Modified transfacet approach
Surgical treatment
Thoracic spine tuberculosis
author_facet Yun-Peng Huang
Jian-Hua Lin
Xiao-Ping Chen
Gui Wu
Xuan-Wei Chen
author_sort Yun-Peng Huang
title Preliminary experience in treating thoracic spinal tuberculosis via a posterior modified transfacet debridement, instrumentation, and interbody fusion
title_short Preliminary experience in treating thoracic spinal tuberculosis via a posterior modified transfacet debridement, instrumentation, and interbody fusion
title_full Preliminary experience in treating thoracic spinal tuberculosis via a posterior modified transfacet debridement, instrumentation, and interbody fusion
title_fullStr Preliminary experience in treating thoracic spinal tuberculosis via a posterior modified transfacet debridement, instrumentation, and interbody fusion
title_full_unstemmed Preliminary experience in treating thoracic spinal tuberculosis via a posterior modified transfacet debridement, instrumentation, and interbody fusion
title_sort preliminary experience in treating thoracic spinal tuberculosis via a posterior modified transfacet debridement, instrumentation, and interbody fusion
publisher BMC
series Journal of Orthopaedic Surgery and Research
issn 1749-799X
publishDate 2018-11-01
description Abstract Background Posterior transfacet approach has been proved to be a safe and effective access to treat thoracic disc herniation. However, the therapeutic effect and safety of modified transfacet approach for treating thoracic spinal tuberculosis (TST) has not been reported in the clinical literature. In this study, the clinical efficacy and safety of a single-stage posterior modified transfacet debridement, posterior instrumentation, and interbody fusion for treating TST were retrospectively evaluated. Patients and methods From 2009 to 2014, 37 patients with TST underwent a posterior modified transfacet debridement, interbody fusion following posterior instrumentation, under the cover of 18 months of antituberculosis chemotherapy. The patients were evaluated preoperatively and postoperatively in terms of Frankel Grade, visual analog scale (VAS) pain score, kyphotic Cobb angle, and bony fusion. Results The follow-up time was 39.8 ± 5.1 months (29–50 months). No postoperative complication or recurrence of spinal tuberculosis was observed. Definitive bony fusion was achieved in all patients. At the final follow-up, 2 cases were rated as Frankel grade D, 35 as grade E. VAS was recovered from 8.4 ± 1.0 cm to 0.4 ± 0.8 cm. The kyphotic angles were corrected from 29.4 ± 10.9° to 17.6 ± 6.3°. Using the Kirkaldy-Willis criteria, functional outcome was excellent in 29 patients, good in 7, and fair in 1. Conclusions Our preliminary results showed that single-stage posterior modified transfacet debridement, posterior instrumentation, and interbody fusion are effective and safe surgical options for treating TST.
topic Focal debridement
Modified transfacet approach
Surgical treatment
Thoracic spine tuberculosis
url http://link.springer.com/article/10.1186/s13018-018-0994-8
work_keys_str_mv AT yunpenghuang preliminaryexperienceintreatingthoracicspinaltuberculosisviaaposteriormodifiedtransfacetdebridementinstrumentationandinterbodyfusion
AT jianhualin preliminaryexperienceintreatingthoracicspinaltuberculosisviaaposteriormodifiedtransfacetdebridementinstrumentationandinterbodyfusion
AT xiaopingchen preliminaryexperienceintreatingthoracicspinaltuberculosisviaaposteriormodifiedtransfacetdebridementinstrumentationandinterbodyfusion
AT guiwu preliminaryexperienceintreatingthoracicspinaltuberculosisviaaposteriormodifiedtransfacetdebridementinstrumentationandinterbodyfusion
AT xuanweichen preliminaryexperienceintreatingthoracicspinaltuberculosisviaaposteriormodifiedtransfacetdebridementinstrumentationandinterbodyfusion
_version_ 1724946767837921280